Nationwide recall on these compound GLP-1 drugs
myfox8.com
Nationwide recall on these compound GLP-1 drugs
The compounded GLP-1s are not FDA-approved nor name-brand.
Replies0 Reposts0 Likes1
A Medsky Topics feed composed of posts covering recent news related to GLP-1 Agonists such as Semaglutide (Ozempic, Wegovy, Rybelsus), Liraglutide (Victoza), and Tirzepatide (Zepbound, Mounjaro) Powered by @medsky.network
- 16
- Likes
- +0
- Growth per month
In the feed right now
Live from Bluesky 
ID fellow Raymond Smith, MD, presents research on prior GLP-1 receptor agonist use and infection outcomes in solid organ transplant patients during the #IDWeek2026 Rapid-Fire Poster Session: Transplant Rapid Fire.
Don't miss tomorrow's presentations at 12:15pm-12:45pm in the RF Arena!
Replies1 Reposts0 Likes1
A leading medical body’s guidelines on GLP-1 use during and after pregnancy have opened the door to using the drug while nursing. on.wsj.com/4jCxc04
on.wsj.com
A No-No During Pregnancy, Weight-Loss Drugs May Be OK While Breast-Feeding
A leading medical body’s guidelines on GLP-1 use during and after pregnancy have opened the door to using the drug while nursing.
Replies0 Reposts1 Likes6
Nutritional, functional, and psychological considerations for #incretin-based therapies in adults—an EASO, EFAD, and ECPO Consensus Statement www.thelancet.com/journal….
#obesity #weightloss
#FREE to read with registration (also FREE)
#MedSky #EndoSky #PsychSky
www.thelancet.com
Nutritional, functional, and psychological considerations for incretin-based therapies in adults—an EASO, EFAD, and ECPO Consensus Statement
Incretin-based therapies, including GLP-1 receptor agonists and dual GLP-1–GIP receptor agonists, have transformed obesity management, producing substantial weight loss and cardiometabolic benefits, w...
Replies0 Reposts0 Likes0
Today in #Employer Coverage: Friday Shorts and Followups: Premiums, #GLP-1 compounding ingredient safety, arbitration profits, and vaccine views @kff.org @statnews.com @tarabannow.bsky.social @bloomberg.com
employercoverage.substack….
employercoverage.substack.com
Friday Shorts and Followups: Premiums, GLP-1 Ingredient Safety, Arbitration Profits, and Vaccine Views
October 23, 2026
Replies0 Reposts0 Likes0
Boom in weight-loss drugs could lead to drop in beer sales, Heineken warns British pubs
www.theguardian.com
Boom in weight-loss drugs could lead to drop in beer sales, Heineken warns British pubs
World’s second largest brewer says use of drugs such as Wegovy can reduce desire to drink alcohol Heineken has warned British bars and pubs that the boom in popularity of weight-loss drugs could lead to a fall in sales of beer and cider. The world’s second largest brewer sent a presentation to British hospitality customers earlier this month warning that GLP-1 use – led by Ozempic and Wegovy – can reduce the desire to drink alcohol, which could lead to “fullness and fewer serves” of pints in pubs and bars. Continue reading...
Replies12 Reposts6 Likes27
Listen to the 2025 Blue Book chapter, “GLP-1 receptor agonists – an evolving paradigm in perioperative medication management”. You can find the full chapter on Soundcloud – no account required, and you can download the chapter for easy offline listening: bit.ly/4zMA3YW
Replies0 Reposts0 Likes2
Speakers at sponsored event questioned evidence linking obesity to poor health and said drugs such as Ozempic and Mounjaro were tools for ‘indoctrination’
www.thetimes.com
Weight-loss jabs are ‘imperialist’, Harvard activists say
Replies1 Reposts1 Likes2
Have you tried microdosing a GLP-1 drug?
We’re working on a story about a new trend in the world of GLP-1 medications: microdosing. Have you tried it? Why? How did you get it? And what was your experience like?
Leave us a voicemail with your story or your questions at 877-4-SCIFRI.
Replies4 Reposts8 Likes15
About 1 in 5 large firms cover GLP-1 drugs specifically for weight loss, often with restrictions.
Over half who currently cover the drugs for weight loss say it’s had either a significant (29%) or moderate (27%) impact on their prescription drug spending.
More details: on.kff.org/ehbs2026
Replies0 Reposts0 Likes0